Literature DB >> 11873012

Anti-idiotypic antibody Ab2/3H6 mimics the epitope of the neutralizing anti-HIV-1 monoclonal antibody 2F5.

Renate E Kunert1, Robert Weik, Boris Ferko, Gabriela Stiegler, Hermann Katinger.   

Abstract

Anti-idiotypic antibodies directed against potentially neutralizing anti-HIV-1 antibodies may mimic epitopes on gp41 otherwise cryptic to the immune system. This study reports the generation of murine monoclonal antibody Ab2/3H6 blocking the binding of human Ab1 2F5 to the synthetic epitope and to gp160 in an enzyme-linked immunosorbent competition assay. Ab2/2H6 diminished the neutralizing potency of 2F5 in an in-vitro neutralization assay. Ab2/3H6 Fab fragments were capable of inducing neutralizing immune and 2F5-specific responses in B6D2F1 mice applying a simple prime-boost regimen of immunization.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11873012     DOI: 10.1097/00002030-200203080-00020

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  5 in total

1.  Expression, purification, and in vivo administration of a promising anti-idiotypic HIV-1 vaccine.

Authors:  Johannes Simon Gach; Heribert Quendler; Boris Ferko; Hermann Katinger; Renate Kunert
Journal:  Mol Biotechnol       Date:  2008-06       Impact factor: 2.695

2.  Evaluation of the potency of the anti-idiotypic antibody Ab2/3H6 mimicking gp41 as an HIV-1 vaccine in a rabbit prime/boost study.

Authors:  Alexander Mader; Renate Kunert
Journal:  PLoS One       Date:  2012-06-15       Impact factor: 3.240

3.  Anti-idiotypic antibody Ab2/3H6 mimicking gp41: a potential HIV-1 vaccine?

Authors:  Renate Kunert; Alexander Mader
Journal:  BMC Proc       Date:  2011-11-22

4.  Antibody humanization by molecular dynamics simulations-in-silico guided selection of critical backmutations.

Authors:  Christian Margreitter; Patrick Mayrhofer; Renate Kunert; Chris Oostenbrink
Journal:  J Mol Recognit       Date:  2016-01-08       Impact factor: 2.137

5.  Lessons learned from merging wet lab experiments with molecular simulation to improve mAb humanization.

Authors:  L Schwaigerlehner; M Pechlaner; P Mayrhofer; C Oostenbrink; R Kunert
Journal:  Protein Eng Des Sel       Date:  2018-07-01       Impact factor: 1.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.